Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Central Nervous System Neoplasm

fluorodeoxyglucose f18 has been researched along with Central Nervous System Neoplasm in 40 studies

Research

Studies (40)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.50)	18.2507
2000's	7 (17.50)	29.6817
2010's	23 (57.50)	24.3611
2020's	9 (22.50)	2.80

Authors

Authors	Studies
Fujimoto, S; Ishishita, Y; Kawai, K; Koide, R; Mashiko, T; Matsuzono, K; Ohtani, K; Ozawa, T; Tanaka, R; Yagisawa, T; Yamaguchi, T	1
Alentorn, A; Hernandez-Verdin, I; Hoang-Xuan, K; Houillier, C; Morales-Martinez, A; Nichelli, L	1
Honda, T; Inoue, A; Kanno, K; Kinnami, S; Kitazawa, R; Kunieda, T; Kurata, M; Kusakabe, K; Matsumoto, S; Miyazaki, Y; Ohnishi, T; Shigekawa, S; Suehiro, S; Taniwaki, M; Watanabe, H; Yamashita, D	1
Appaduray, SP; Chan, J; Khoo, J; Somasundaram, N; Yan, SX	1
Dormont, D; Galanaud, D; Kas, A; Pyatigorskaya, N; Soussain, C	1
Chae, SY; Huh, JR; Kim, HO; Kim, JH; Kim, JS; Kim, SO; Lee, SH; Oh, JS; Oh, SJ; Ryu, JS; Seo, M	1
Gupta, T; Kannan, S; Manjali, JJ; Purandare, N; Rangarajan, V	2
Attygalle, A; Chau, I; Cunningham, D; El-Sharkawi, D; Goldman, A; Iyengar, S; Kowa, JY; Li, S; Mackinnon, A; Mahalingam, P; Marshall, K; Millard, T; Nicholson, E; Rich, P; Sharma, B; Sharma, RK; Welsh, L	1
Chen, Z; Jiang, J; Leng, H; Pan, M; Tong, J; Zou, Y	1
Huh, J; Jo, JC; Kang, EH; Kim, JH; Kim, S; Lee, K; Lee, SW; Park, CS; Park, JS; Ryu, JS; Suh, C; Yoon, DH	1
Ahn, JS; Ahn, SY; Bom, HS; Jung, SH; Ki, SY; Kim, HJ; Kwon, SY; Lee, JJ; Min, JJ; Song, SY; Yang, DH; Yoo, SW	1
Amlal, S; Bahloul, A; Marie, PY; Perrin, M; Verger, A	1
Barré, L; Fillesoye, F; Gourand, F; Guillouet, S; Hovhannisyan, N; Ibazizene, M; Plancoulaine, B; Toutain, J; Valable, S	1
Jara, H	1
Gelfand, MJ; Parisi, MT; Sharp, SE; Shulkin, BL; Yanik, GA	1
Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G	1
Ando, Y; Fujii, M; Kato, K; Maesawa, S; Naganawa, S; Nihashi, T; Okada, Y; Okochi, Y; Takebayashi, S; Wakabayashi, T	1
Akai, T; Iizuka, H; Sasagawa, Y; Tachibana, O	1
Hwang, GY; Leung, GK; Li, LF; Lui, WM; Pu, JK; Taw, BB	1
Kim, SE; Lee, JS; Lee, WW; Song, YS	1
Baquero, M; Bassa, P; García-Garzon, JR; Riera, E; Soler, M; Villasboas-Rosciolesi, D	1
Ge, J; Guan, Y; Zhao, G; Zuo, C	1
Chua, SC; O'Connor, SR; Rozalli, FI	1
Kawai, N; Maeda, Y; Miyake, K; Nishiyama, Y; Okubo, S; Tamiya, T; Yamamoto, Y	1
Kawai, N; Miyake, K; Nishiyama, Y; Tamiya, T; Yamamaoto, Y; Zhen, HN	1
Kameyama, R; Kawai, N; Kawase, Y; Kudomi, N; Nishiyama, Y; Yamamoto, Y	1
Sathekge, MM; Warwick, JM	1
Bhogal, P; Booth, TC; Malhotra, A; Tang, YZ; Wilhelm, T	1
Blay, JY; Cimarelli, S; Ghesquières, H; Sebban, C; Sunyach, MP; Thiesse, P	1
Guillevin, R; Noël, G	1
Finke, J; Fritsch, K; Hader, C; Haug, V; Illerhaus, G; Kasenda, B; Meyer, PT; Mix, M; Schorb, E; Weber, WA	1
Chen, Z; Shi, X; Wang, X; Yi, C; Zhang, B; Zhang, X	1
Bender, H; Biersack, HJ; Bucerius, J; Joe, A; Linnebank, M; Matthies, A; Palmedo, H; Pels, H; Schlegel, U; Schmidt-Wolf, IG; Urbach, H	1
Kaburaki, J; Kubo, A; Nakahara, T; Shiga, H; Takagi, Y; Uchida, H	1
Karantanis, D; Lowe, VJ; Mullan, BP; Nathan, MA; O'eill, BP; Peller, PJ; Subramaniam, RM; Wiseman, GA; Witte, RJ	1
Hampson, FA; Shaw, AS	1
Abrey, LE; Deangelis, LM; Mohile, NA	1
Pauwels, EK; Stokkel, MP; van der Hiel, B	1
Coleman, RE; Glantz, MJ; Hanson, MW; Hoffman, JM; Rosenfeld, SS; Schold, SC	1

Reviews

11 review(s) available for fluorodeoxyglucose f18 and Central Nervous System Neoplasm

Article	Year
Prognostic factors in primary central nervous system lymphoma. Current opinion in oncology, 2022, 11-01, Volume: 34, Issue:6 Topics: Artificial Intelligence; Biological Products; Biomarkers; Central Nervous System; Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Interleukin-10; Lymphoma, Large B-Cell, Diffuse; Prognosis	2022
Diagnostic Yield of Extensive Systemic Staging Including Whole-body 18F-fluoro-deoxy-glucose Positron Emission Tomography With or Without Computed Tomography in Patients With Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis. Clinical lymphoma, myeloma & leukemia, 2020, Volume: 20, Issue:11 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2020
Diagnostic Performance of Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography With or Without Computed Tomography in Patients With Primary Central Nervous System Lymphoma: Updated Systematic Review and Diagnostic Test Accuracy Meta-analyses. Clinical lymphoma, myeloma & leukemia, 2021, Volume: 21, Issue:8 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neuroimaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity	2021
Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis. Oncotarget, 2017, Jun-20, Volume: 8, Issue:25 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Immunocompetence; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2017
Functional-metabolic imaging of neuroblastoma. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013, Volume: 57, Issue:1 Topics: 3-Iodobenzylguanidine; Central Nervous System Neoplasms; Child; Child, Preschool; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Medical Oncology; Neuroblastoma; Prognosis; Radionuclide Imaging; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging	2013
PET/CT imaging in neuroblastoma. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013, Volume: 57, Issue:1 Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Central Nervous System Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; Ephedrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Models, Biological; Models, Chemical; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed	2013
Imaging features of primary extranodal lymphomas. Clinical radiology, 2009, Volume: 64, Issue:6 Topics: Adrenal Gland Neoplasms; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Digestive System Neoplasms; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed; Urogenital Neoplasms	2009
PET/CT scanning with a high HIV/AIDS prevalence. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2011, Volume: 44, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Central Nervous System Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; HIV Seropositivity; Humans; Lipodystrophy; Lymph Nodes; Lymphoma; Positron-Emission Tomography; Prevalence; Radionuclide Imaging; Radiopharmaceuticals; Thymus Gland; Tomography, X-Ray Computed	2011
Imaging of primary central nervous system lymphoma. Clinical radiology, 2011, Volume: 66, Issue:8 Topics: Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Spectroscopy; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed	2011
Response assessment in lymphoma. Clinical radiology, 2008, Volume: 63, Issue:2 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIa: Therapy response monitoring in breast cancer, lymphoma and gliomas. Journal of cancer research and clinical oncology, 2001, Volume: 127, Issue:5 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Central Nervous System Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Rats; Tomography, Emission-Computed	2001

Other Studies

29 other study(ies) available for fluorodeoxyglucose f18 and Central Nervous System Neoplasm

Article	Year
Case report of an elderly woman with atypical imaging for primary central nervous system lymphoma who needed a brain biopsy for diagnosis. The Journal of international medical research, 2021, Volume: 49, Issue:8 Topics: Aged; Biopsy; Brain; Central Nervous System; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed	2021
What is the Best Preoperative Quantitative Indicator to Differentiate Primary Central Nervous System Lymphoma from Glioblastoma? World neurosurgery, 2023, Volume: 172 Topics: Brain Neoplasms; Central Nervous System; Central Nervous System Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Tomography, X-Ray Computed	2023
Early Detection of Secondary Central Nervous System Lymphoma on PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:5 Topics: Central Nervous System Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography	2020
Low ADC in CNS Lymphoma. Clinical nuclear medicine, 2020, Volume: 45, Issue:7 Topics: Aged, 80 and over; Central Nervous System Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Ischemia; Lymphoma; Magnetic Resonance Imaging	2020
Clinicopathological characteristics of primary central nervous system lymphoma with low 18F-fludeoxyglucose uptake on brain positron emission tomography. Medicine, 2020, Volume: 99, Issue:20 Topics: Adult; Aged; Brain Neoplasms; Carcinogenesis; Central Nervous System Neoplasms; Cerebrospinal Fluid Proteins; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Interferon Regulatory Factors; Ki-67 Antigen; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Retrospective Studies; Steroids	2020
Are treatment response assessment maps (TRAMs) and British journal of haematology, 2021, Volume: 195, Issue:1 Topics: Central Nervous System Neoplasms; Cerebellar Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Multimodal Imaging; Neuroimaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2021
Interim Annals of hematology, 2017, Volume: 96, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Registries; Retrospective Studies; Survival Rate	2017
Prognostic Significance of Interim 11C-Methionine PET/CT in Primary Central Nervous System Lymphoma. Clinical nuclear medicine, 2018, Volume: 43, Issue:8 Topics: Adult; Aged; Carbon Radioisotopes; Central Nervous System Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methionine; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2018
Central Nervous System Myelomatosis Delineated by High-Resolution Brain Images From Fully Digital 18F-FDG PET. Clinical nuclear medicine, 2018, Volume: 43, Issue:10 Topics: Brain; Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Sensitivity and Specificity	2018
[ Theranostics, 2018, Volume: 8, Issue:16 Topics: Animals; Central Nervous System Neoplasms; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Heterografts; Histocytochemistry; Humans; Image Processing, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Nude; Sensitivity and Specificity; Vidarabine	2018
Primary Central Nervous System Lymphoma: Lessons and Opportunities from 2 Decades of CT and PET/CT. Radiology, 2019, Volume: 292, Issue:2 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2019
Clinical use of (11)C-methionine and (18)F-FDG-PET for germinoma in central nervous system. Annals of nuclear medicine, 2014, Volume: 28, Issue:2 Topics: Adolescent; Adult; Brain; Carbon Radioisotopes; Central Nervous System Neoplasms; Child; Female; Fluorodeoxyglucose F18; Germinoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methionine; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult	2014
Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system. Journal of neuro-oncology, 2015, Volume: 121, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Brain Diseases; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Interleukin-10; Interleukin-6; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Interleukin-2; ROC Curve; Sensitivity and Specificity	2015
Primary Central Nervous System Natural Killer Cell Lymphoma in a Chinese Woman with Atypical (11)C-Choline Positron Emission Tomography and Magnetic Resonance Spectrometry Findings. World neurosurgery, 2015, Volume: 84, Issue:4 Topics: Adult; Central Nervous System Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Glioma; Humans; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Magnetic Resonance Spectroscopy; Neurosurgical Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome	2015
Prediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography. Medicine, 2015, Volume: 94, Issue:44 Topics: Central Nervous System Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
A False-Negative Case of Primary Central Nervous System Lymphoma on 11C-Methionine PET and Intense 18F-FDG Uptake. Clinical nuclear medicine, 2016, Volume: 41, Issue:8 Topics: Adult; Carbon Radioisotopes; Central Nervous System Neoplasms; False Negative Reactions; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methionine; Positron-Emission Tomography; Radiopharmaceuticals	2016
Enhanced MRI and 18F-FDG PET/CT Findings of Primary Central Nervous System Lymphoma Mimicking Encephalitis. Clinical nuclear medicine, 2016, Volume: 41, Issue:10 Topics: Brain; Central Nervous System Neoplasms; Diagnosis, Differential; Encephalitis; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography	2016
Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings. Annals of nuclear medicine, 2010, Volume: 24, Issue:5 Topics: Adult; Aged; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; Retrospective Studies	2010
Prognostic value of pretreatment 18F-FDG PET in patients with primary central nervous system lymphoma: SUV-based assessment. Journal of neuro-oncology, 2010, Volume: 100, Issue:2 Topics: Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies	2010
Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma. Molecular imaging and biology, 2011, Volume: 13, Issue:6 Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lymphoma; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiography	2011
Use of F-18 FDG PET/CT in non-Hodgkin lymphoma with central nervous system involvement. Clinical nuclear medicine, 2011, Volume: 36, Issue:6 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
[Delineation of glioblastoma, simplicity to complexity, the contribution of imaging]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2011, Volume: 15, Issue:6-7 Topics: Carbon Radioisotopes; Central Nervous System Neoplasms; Clinical Trials as Topic; Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Methionine; Neoplasm Recurrence, Local; Organs at Risk; Positron-Emission Tomography; Radiopharmaceuticals; Societies, Medical; Tomography, X-Ray Computed; Tumor Burden	2011
18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Brain; Central Nervous System Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Genetic Markers; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Risk; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2013
The combination of 13N-ammonia and 18F-FDG in predicting primary central nervous system lymphomas in immunocompetent patients. Clinical nuclear medicine, 2013, Volume: 38, Issue:2 Topics: Adult; Aged; Ammonia; Central Nervous System Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Immunocompetence; Lymphoma; Male; Middle Aged; Multimodal Imaging; Nitrogen Radioisotopes; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2013
FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:2 Topics: Aged; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Treatment Outcome	2006
Hypermetabolic change as a possible predictive sign of a relapsed central nervous system lymphoma. Clinical nuclear medicine, 2007, Volume: 32, Issue:2 Topics: Central Nervous System Neoplasms; Dysarthria; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography; Recurrence	2007
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients. Nuclear medicine communications, 2007, Volume: 28, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Central Nervous System Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; HIV Seronegativity; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Rituximab	2007
The utility of body FDG PET in staging primary central nervous system lymphoma. Neuro-oncology, 2008, Volume: 10, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography	2008
Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Tomography, Emission-Computed	1992